Corrigendum to "Design, molecular docking, and molecular dynamics of thiourea-iron (III) metal complexes as NUDT5 inhibitors for breast cancer treatment" [Heliyon 8 (9) (2022) e10694]
Heliyon. 2022 Nov 2;8(11):e11273.
doi: 10.1016/j.heliyon.2022.e11273.
eCollection 2022 Nov.